DRREDDYNSEDr. Reddy's Laboratories Limited· PharmaceuticalsMinimalNeutral
Announced Sat, 10 May · 13:20 IST

Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication

DRREDDY · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Dr. Reddy's Laboratories has filed copies of newspaper advertisements published on May 10, 2025 in Business Standard and Andhra Prabha, containing the audited standalone and consolidated financial results for the quarter and full year ended March 31, 2025. The results were approved by the Board of Directors, based on the Audit Committee's recommendation, at their meeting held on May 9, 2025. The filing is being made under Regulation 47 of SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015. The document does not contain the full set of financial figures in a clearly readable form, so specific revenue or profit numbers for the company cannot be confirmed from the filing. Full results are available on the company's website and on stock exchange portals.

Likely market impact

This is a routine regulatory compliance filing confirming that Dr. Reddy's Q4 and FY25 audited results have been made public via newspaper publication; it does not itself contain new financial information and is unlikely to move the stock price.